Decipher Labs Ltd (DECIPHER) is currently trading at 6.12 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Decipher Labs Ltd., formerly known as Combat Drugs Ltd, is a diversified public company engaged in manufacturing and marketing pharmaceuticals and providing IT solutions. The company has expanded its operations with the acquisition of Decipher Software Solutions LLC in the USA, indicating a strategic focus on IT solutions. Decipher Labs has a reputable presence in the pharmaceutical sector, manufacturing and marketing branded formulations, bulk drugs, and chemical supplies accepted by the trade and medical community. The company operates a full-fledged manufacturing unit in Hyderabad, producing various pharmaceutical formulations including tablets, capsules, and liquids. Decipher Labs is actively exploring export opportunities to Nigeria and the West Indies, signaling a potential increase in international market exposure.

Over the past 52 weeks, Decipher Labs Ltd has traded between a low of ₹5.69 and a high of ₹12.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Decipher Labs Ltd has a market capitalization of approximately 5.87. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Decipher Labs Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -0.77 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 5.87 Cr, Decipher Labs Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Decipher Labs Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Decipher Labs Ltd is -0.77. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.